Alternative names (1)
hasBlackBoxWarningRandom triples
| Subject | Object |
|---|---|
| gptkb:gemtuzumab_ozogamicin | veno-occlusive disease |
| gptkb:Depakote | hepatotoxicity |
| gptkb:fluoroquinolones | tendinitis |
| gptkb:Depakote | teratogenicity |
| gptkb:Yescarta | yes |
| gptkb:DB05509 | spinal/epidural hematoma risk |
| gptkb:Ipilimumab | immune-mediated adverse reactions |
| gptkb:DB09278 | risk of hepatitis B reactivation |
| gptkb:Hysingla_ER | interaction with alcohol |
| gptkb:Leqembi | yes |
| gptkb:Natpara | risk of osteosarcoma |
| gptkb:Ativan | concomitant use with opioids may cause respiratory depression, coma, and death |
| gptkb:relmacabtagene_autoleucel | cytokine release syndrome |
| gptkb:Tarceva | hepatic failure |
| gptkb:DB09053 | risk of spinal/epidural hematoma |
| gptkb:Alvimopan | true |
| gptkb:Suvorexant | no |
| gptkb:DB08865 | increased risk of thrombotic events after premature discontinuation |
| gptkb:Tarceva | gptkb:interstitial_lung_disease |
| gptkb:fluoroquinolones | CNS effects |